558 results on '"Hyett, J"'
Search Results
152. Endoscopic laser coagulation of umbilical cord vessels in twin reversed arterial perfusion sequence
153. The Association Between Induction of Labor at 38 to 39 Weeks Pregnancy and Indication for Cesarean Delivery: An Observational Study.
154. Obstetric outcome after threatened miscarriage with and without a hematoma on ultrasound.
155. OC05.08: Prenatal screening and testing for 45,X: lessons learned from 18,299 cfDNA results from the SMART study.
156. OC05.04: Prenatal screening for 22q11.2DS: does it change patient care?
157. First trimester screening for fetal abnormalities.
158. Biochemical analyses of mesenchymal fluid in early pregnancy.
159. Morphometric analysis of the great vessels in early fetal life.
160. Is Ultrasound Measured Fetal Biometry Predictive of Intrapartum Cesarean Section for Failure to Progress?
161. Nuchal translucency and the risk of congenital heart disease.
162. Cardiac gene expression of GATA-4 transcription factor in human trisomy 21 fetuses with increased nuchal translucency
163. Increased nuchal translucency in trisomy 21 fetuses: relationship to narrowing of the aortic isthmus.
164. Indications for Caesarean Section: Time Trends Over 27 Years in Two Sydney Metropolitan Hospitals
165. Evaluation of non-invasive prenatal RHD genotyping of the fetus
166. Fetal testing in intra-uterine growth retardation
167. Register of Australian Oilseed Cultivars. Brassica napus (L) var. napus (L) (Rapeseed) cv. Taparoo
168. Book Review: Australian Mammals
169. Register of Australian Oilseed Cultivars. Brassica napus (L) var. napus (Rapeseed) cv. Wesbarker
170. The Role of Aspirin Dose on the Prevention of Preeclampsia and Fetal Growth Restriction: Systematic Review and Meta-Analysis.
171. Abstracts of the 26th World Congress on Ultrasound in Obstetrics and Gynecology, Rome, Italy, 24-28 September 2016.
172. Combined first trimester or cffDNA screening.
173. Patient choice and the randomized controlled trial.
174. Reliability of prenatal sexing by non-invasive diagnosis using real time PCR.
175. Free Fetal DNA in Maternal Plasma for Diagnosis of Haemoglobin Disorder.
176. Vaginal progesterone for prevention of preterm birth in asymptomatic high-risk women with a normal cervical length: a systematic review and meta-analysis.
177. Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios.
178. Cost‐effectiveness analysis of a model of first‐trimester prediction and prevention of preterm pre‐eclampsia compared with usual care.
179. The ultrasound assessment of adipose tissue deposition in fetuses of 'well controlled' insulin-dependent diabetic pregnancies.
180. Performance of six birth-weight and estimated-fetal-weight standards for predicting adverse perinatal outcome: a 10-year nationwide population-based study.
181. Ultrasound features prior to 11 weeks' gestation and first-trimester maternal factors in prediction of hypertensive disorders of pregnancy.
182. From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach.
183. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction.
184. Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia.
185. Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation.
186. EP12.03: Performance analysis of cfDNA in predicting sex chromosome count in an unselected population.
187. OP09.05: Prediction of pre‐eclampsia using machine learning.
188. VP37.10: Performance of routine first trimester combined screening for preterm pre‐eclampsia after multicentre clinical implementation in Australia.
189. OC07.06: Pregnancy outcomes following multicentre clinical implementation of routine first trimester screening for preterm pre‐eclampsia in Australia.
190. Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening.
191. Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening.
192. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.
193. First-trimester fetal nasal bone audit: evaluation of a novel method of image assessment.
194. VP52.21: Shear wave elastography: the relationship of cervical stiffness with gestational age and cervical length.
195. VP52.18: The Arabin pessary with dilated cervix: two distinct populations and outcomes.
196. VP52.09: Do we really know how the Arabin pessary works in women at risk for preterm birth?
197. VP49.02: Prediction of preterm prelabour rupture of membranes.
198. VP34.08: Long‐term evaluation of retention of acquired ultrasound theoretical knowledge and skills following an intensive ISUOG ultrasound course in the Sultanate of Oman.
199. P13.04: A combination of ultrasound features and maternal biochemistry can predict pre‐eclampsia prior to 11 weeks of gestation.
200. OP18.07: First trimester ultrasound features associated with subsequent miscarriage: a prospective study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.